Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed) (RFA-HL-23-006)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

APOE Biology in Alzheimer’s (ABA)

Sponsor: Alzheimer's Association

Award: Maximum grant amount is $300,000.

Due Date: Letter of Intent due by February 24, 2022 at 5 p.m. EST.

Young Researcher Program

Sponsor: Fondation Alzheimer (France)

Award: €200,000

Due Date: April 30, 2022

Grant: Innovative Project Grant_LOI

Sponsor: Fondation Alzheimer (France)

Award: €100,000

Due Date: April 30, 2022

Joel Menard Award

Sponsor: Fondation Alzheimer (France)

Award: €2500

Due Date: April 30, 2022

AFI Standard- und Pilot-Projekte

Sponsor: Alzheimer Forschung Initiative (AFI), Germany

Award: Maximum of €150,000 or €50,000

Due Date: 1 February 2022, 13:00 CET

Call Biomedical Research

Sponsor: Alzheimer Nederland, The Netherlands

Award: Differing amounts, three different grant types of max €50,000, €150,000, and €300,000.

Due Date: 1 February 2022, 13:00 CET

Appel à Projects Annuel

Sponsor: Fondation Vaincre Alzheimer (FVA), France

Award: Multiple amounts, four different grant types of max €40,000, €50,000, €100,000, and €121,000.

Due Date: 1 February 2022, 13:00 CET

Notice of Special Interest (NOSI): Sleep Disorders and Circadian Clock Disruption in Alzheimers Disease and other Dementias of Aging (NOT-AG-21-051)

Sponsor: National Institute on Aging, National Institute of Neurological Disorders and Stroke

Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) (PAR-21-357)

Sponsor: National Institutes of Health

Due Date: Multiple due dates, see announcement.

Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional) (PAR-21-359)

Sponsor: National Institute on Aging

Due Date: Multiple due dates, see announcement.

Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional) (PAR-21-360)

Sponsor: National Institute on Aging

Due Date: Multiple due dates, see announcement.

Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) (PAR-22-060)

Sponsor: National Institutes of Health

Due Date: Multiple due dates; see announcement.

Notice of Special Interest (NOSI): Infectious Etiology of Alzheimer's Disease (NOT-AG-21-043)

Sponsor: National Institute on Aging

Notice of Special Interest (NOSI): Deciphering the Glycosylation Code of Alzheimer's Disease (NOT-AG-21-042)

Sponsor: National Institute on Aging